← Open Payments lookup

ROBERT RILEY: Open Payments

NPI 1871608562 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$673 in 26 payments from 11 companies in 2025. Trend: 2023 $409 · 2024 $477 · 2025 $673

Food & beverage: $581Education: $91
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.4$170
E.R. Squibb & Sons, L.L.C.6$151
Otsuka America Pharmaceutical, Inc.3$82
ABBVIE INC.4$80
Collegium Pharmaceutical, Inc.2$49
Janssen Pharmaceuticals, Inc2$46
Vanda Pharmaceuticals Inc.1$24
Axsome Therapeutics, Inc.1$20
Alkermes, Inc.1$18
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$17

Products named: COBENFY, VRAYLAR, UZEDY, ABILIFY MAINTENA, Jornay PM, REXULTI, INVEGA SUSTENNA, HETLIOZ.

Industry payments across MD — which companies pay providers there.